Market Closed -
Nasdaq
01:30:00 11/05/2024 am IST
|
5-day change
|
1st Jan Change
|
1.8
USD
|
-0.55%
|
|
-5.26%
|
-51.74%
|
Fiscal Period: December |
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Capitalization
1 |
573.7
|
158.7
|
151.9
|
73.48
|
-
|
Enterprise Value (EV)
1 |
573.7
|
158.7
|
151.9
|
73.48
|
73.48
|
P/E ratio
|
-33.6
x
|
-3.34
x
|
-3.22
x
|
-2.22
x
|
-3.51
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
15.5
x
|
3.83
x
|
4.14
x
|
1.9
x
|
1.6
x
|
EV / Revenue
|
15.5
x
|
3.83
x
|
4.14
x
|
1.9
x
|
1.6
x
|
EV / EBITDA
|
-75.3
x
|
-7.24
x
|
-7.9
x
|
-4.58
x
|
-7.04
x
|
EV / FCF
|
-
|
-
|
-5.7
x
|
-4.08
x
|
-11.7
x
|
FCF Yield
|
-
|
-
|
-17.5%
|
-24.5%
|
-8.57%
|
Price to Book
|
-
|
-
|
1.32
x
|
-
|
-
|
Nbr of stocks (in thousands)
|
28,012
|
28,130
|
40,728
|
40,823
|
-
|
Reference price
2 |
20.48
|
5.640
|
3.730
|
1.800
|
1.800
|
Announcement Date
|
15/03/22
|
15/03/23
|
11/03/24
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net sales
1 |
31.3
|
36.89
|
41.42
|
36.68
|
38.71
|
46
|
EBITDA
1 |
-
|
-7.614
|
-21.93
|
-19.23
|
-16.04
|
-10.43
|
EBIT
1 |
-
|
-12.01
|
-49.66
|
-35.56
|
-27.99
|
-24.28
|
Operating Margin
|
-
|
-32.55%
|
-119.89%
|
-96.94%
|
-72.3%
|
-52.77%
|
Earnings before Tax (EBT)
1 |
-
|
-12.64
|
-49.39
|
-37.08
|
-28.52
|
-25.11
|
Net income
1 |
-
|
-9.803
|
-47.47
|
-36.78
|
-27.81
|
-24.48
|
Net margin
|
-
|
-26.57%
|
-114.6%
|
-100.26%
|
-71.84%
|
-53.21%
|
EPS
2 |
0.1600
|
-0.6100
|
-1.690
|
-1.160
|
-0.8100
|
-0.5133
|
Free Cash Flow
1 |
-
|
-
|
-
|
-26.64
|
-18
|
-6.3
|
FCF margin
|
-
|
-
|
-
|
-72.61%
|
-46.5%
|
-13.69%
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
14/05/21
|
15/03/22
|
15/03/23
|
11/03/24
|
-
|
-
|
Fiscal Period: December |
2021 Q3
|
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
---|
Net sales
1 |
9.392
|
10.11
|
11.15
|
11.69
|
10.69
|
7.891
|
9.121
|
11.53
|
8.169
|
7.867
|
8.624
|
9.291
|
10.18
|
10.61
|
10.22
|
EBITDA
1 |
-2.698
|
-3.398
|
-4.305
|
-4.9
|
-4.608
|
-8.114
|
-7.816
|
-2.269
|
-5.477
|
-5.418
|
-5.744
|
-4.01
|
-3.22
|
-3.067
|
-3.22
|
EBIT
1 |
-3.888
|
-4.767
|
-5.843
|
-6.626
|
-22.95
|
-14.24
|
-8.946
|
-4.802
|
-8.762
|
-10.86
|
-9.185
|
-6.834
|
-5.898
|
-6.02
|
-6.774
|
Operating Margin
|
-41.4%
|
-47.15%
|
-52.42%
|
-56.68%
|
-214.68%
|
-180.41%
|
-98.08%
|
-41.66%
|
-107.26%
|
-138.02%
|
-106.5%
|
-73.56%
|
-57.94%
|
-56.72%
|
-66.28%
|
Earnings before Tax (EBT)
1 |
-4.143
|
-4.841
|
-5.856
|
-6.598
|
-22.85
|
-14.09
|
-8.835
|
-7.139
|
-10.14
|
-10.96
|
-9.305
|
-6.954
|
-6.068
|
-6.19
|
-6.994
|
Net income
1 |
-3.251
|
-3.647
|
-5.497
|
-6.203
|
-22.47
|
-13.29
|
-8.817
|
-7.154
|
-10.15
|
-10.66
|
-9.06
|
-6.794
|
-5.917
|
-6.035
|
-6.827
|
Net margin
|
-34.61%
|
-36.07%
|
-49.31%
|
-53.06%
|
-210.19%
|
-168.47%
|
-96.67%
|
-62.06%
|
-124.29%
|
-135.45%
|
-105.04%
|
-73.13%
|
-58.13%
|
-56.87%
|
-66.8%
|
EPS
2 |
-0.1200
|
-0.1300
|
-0.2000
|
-0.2200
|
-0.8000
|
-0.4700
|
-0.3100
|
-0.2500
|
-0.3400
|
-0.2600
|
-0.2467
|
-0.2033
|
-0.1867
|
-0.1800
|
-0.1550
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
10/11/21
|
15/03/22
|
11/05/22
|
10/08/22
|
09/11/22
|
15/03/23
|
11/05/23
|
10/08/23
|
09/11/23
|
11/03/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
---|
Net Debt
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
1 |
-
|
-
|
-
|
-26.6
|
-18
|
-6.3
|
ROE (net income / shareholders' equity)
|
-
|
-
|
-
|
-31.8%
|
-
|
-
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-21.5%
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
170.9
|
-
|
-
|
Book Value Per Share
|
-
|
-
|
-
|
2.830
|
-
|
-
|
Cash Flow per Share
|
-
|
-
|
-
|
-0.5900
|
-
|
-
|
Capex
1 |
-
|
-
|
-
|
7.93
|
4
|
4
|
Capex / Sales
|
-
|
-
|
-
|
21.63%
|
10.33%
|
8.69%
|
Announcement Date
|
14/05/21
|
15/03/22
|
15/03/23
|
11/03/24
|
-
|
-
|
Average target price
5.5
USD Spread / Average Target +205.56% Consensus |
1st Jan change
|
Capi.
|
---|
| -51.74% | 73.48M | | -1.29% | 12.64B | | -0.47% | 8.46B | | +5.68% | 5.66B | | +22.61% | 5.27B | | -2.03% | 4.49B | | -53.56% | 3.11B | | +19.30% | 2.87B | | -8.42% | 2.23B | | -3.55% | 1.89B |
Diagnostic & Testing Substances
|